Icrucumab (Anti-VEGFR1 / FLT1)

Ask supplier a question | View on supplier's website

Icrucumab (Anti-VEGFR1 / FLT1) is a humanized Anti-VEGFR-1 IgG1 monoclonal antibody, with potential anti-tumor and anti-metastatic agent. It also act as a therapeutic anti-angiogenic agent in different pathological contexts.

Supplier	Selleck Chemicals
Product #	A2301
Sku #	A2301-1mg*5
Pricing	1mg*5, $790.00

Feedback